Eli Lilly website screenshot

Eli Lilly

Eli Lilly and Company is a Fortune 500 global pharmaceutical company that discovers, develops, manufactures, and sells human pharmaceutical products in therapeutic areas including diabetes, oncology, immunology, and neuroscience. Eli Lilly does not currently publish a public developer API portal; the company exposes selected machine learning models through its Lilly TuneLab platform to partner biotechs but does not offer general purpose, self-serve APIs.

Eli Lilly is profiled on the APIs.io network. Tagged areas include Fortune 500, Pharmaceuticals, and Life Sciences.

Eli Lilly’s developer surface includes engineering blog and 4 more developer resources.

7.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
Fortune 500PharmaceuticalsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.6/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.7 / 13
Governance 0.0 / 12
Discoverability 5.5 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/eli-lilly: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Eli Lilly Domain Security

TLSv1.3 · DMARC

SECURITY

Press 5

Recent news and press coverage referencing this provider.

Lilly launches TuneLab platform to give biotechnology ...

2026-05-25

Lilly TuneLab™ X revvity signals

2026-05-25

Insilico Medicine Announces Global R&D Collaboration ...

2026-05-25

Insilico Medicine Announces Global R&D Collaboration ...

2026-05-25

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent ...

2026-05-25

Resources

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: eli-lilly
name: Eli Lilly
url: https://raw.githubusercontent.com/api-evangelist/eli-lilly/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
modified: '2026-04-28'
created: '2026-03-21'
specificationVersion: '0.19'
type: Index
position: Consuming
access: 3rd-Party
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/eli-lilly.png
tags:
- Fortune 500
- Pharmaceuticals
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/eli-lilly-domain-security.yml
- type: GitHubOrganization
  url: https://github.com/EliLillyCo
- type: LinkedIn
  url: https://www.linkedin.com/company/eli-lilly-and-company
- type: Website
  url: https://www.lilly.com
- type: Blog
  url: https://www.lilly.com/news/stories
description: Eli Lilly and Company is a Fortune 500 global pharmaceutical company that discovers, develops, manufactures,
  and sells human pharmaceutical products in therapeutic areas including diabetes, oncology, immunology, and neuroscience.
  Eli Lilly does not currently publish a public developer API portal; the company exposes selected machine learning models
  through its Lilly TuneLab platform to partner biotechs but does not offer general purpose, self-serve APIs.
maintainers:
- FN: API Evangelist
  email: info@apievangelist.com